NCT04562103View on ClinicalTrials.gov

Ropivacaine Plasma Concentration With or Without Epinephrine for Posterior Quadratus Lumborum Block

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 3, 2020

Primary Completion Date

August 3, 2020

Study Completion Date

September 3, 2020

Conditions
Local Anesthetic Systemic ToxicityAnesthesia, Local
Interventions
DRUG

Epinephrine / Ropivacaine

In this group quadratus lomborum block was performed with 0.375% ropivacaine+100 mcg epinephrine.

DRUG

Ropivacaine

In this group quadratus lomborum block was performed with plane 0.375% ropivacaine.

Trial Locations (1)

00168

IRCCS Policlinico Agostino Gemelli, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT04562103 - Ropivacaine Plasma Concentration With or Without Epinephrine for Posterior Quadratus Lumborum Block | Biotech Hunter | Biotech Hunter